Patents by Inventor Jes Clausen

Jes Clausen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Interleukin 20 (IL-20) and its use in neovascularisation
    Publication number: 20060188476
    Abstract: The invention provides a novel method of regulating neovascularisation.
    Type: Application
    Filed: January 30, 2006
    Publication date: August 24, 2006
    Applicant: Novo Nordisk A/S
    Inventors: Uffe Olsen, Anker Hansen, John Romer, Erik Hasselager, Jes Clausen, Lars Iversen
  • Human tissue factor antibodies
    Publication number: 20050169927
    Abstract: The present invention relates to isolated fully human antibodies that immunoreacts with human tissue factor (TF) to inhibit the binding of coagulation factor VIIa (FVIIa).
    Type: Application
    Filed: March 31, 2005
    Publication date: August 4, 2005
    Applicant: Novo Nordisk A/S
    Inventors: Per-Ola Freskgaard, Jes Clausen, Brit Sorensen, Marianne Kjalke
  • Human tissue factor antibodies
    Publication number: 20040001830
    Abstract: The present invention relates to isolated fully human antibodies that immunoreacts with human tissue factor (TF) to inhibit the binding of coagulation factor VIIa (FVIIa).
    Type: Application
    Filed: September 30, 2002
    Publication date: January 1, 2004
    Inventors: Per-Ola Freskgaard, Jes Clausen Clausen, Brit Binow Sorensen, Marianne Kjalke